Schroder Investment Management Group Alkermes Plc. Transaction History
Schroder Investment Management Group
- $112 Billion
- Q2 2025
A detailed history of Schroder Investment Management Group transactions in Alkermes Plc. stock. As of the latest transaction made, Schroder Investment Management Group holds 48,506 shares of ALKS stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,506Holding current value
$1.5 Million% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding ALKS
# of Institutions
394Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$901 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$573 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$311 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$254 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$198 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.08B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...